CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 4, 2023 · earnings

EYPT earnings: a negative outcome, -14.2%

On May 4, 2023, EyePoint Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -14.2% in the window around the event. It had already run +104.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$7.90
1d before
$6.78
Event day
$6.54
1d after
$6.50
5d after

Pre-catalyst setup

+104.6%
30-day run-up
24730%
30-day volatility
0.7×
volume spike